DECN

Decision Diagnostics Corp. DECN

DECN
Decision Diagnostics Corp. ROTH
PharmaRoth Labs, Inc. AMBS
Amarantus BioScience Holdings, Inc. PRMD
Primemd Inc. ITMC
Itoco Inc. IBXG
iBX Group, Inc. WIBFF
West Island Brands Inc. SXHHF
Sonomax Technologies Inc LGND
Ligand Pharmaceuticals Incorporated RGDXQ
Response Genetics, Inc

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode DECN ROTH AMBS PRMD ITMC IBXG WIBFF SXHHF LGND RGDXQ
6M 9 900.00 % 0.00 % -96.67 % 0.00 % 200.00 % 0.00 % 0.00 % 0.00 % 75.62 % 0.00 %
YTD 9 900.00 % 0.00 % -90.00 % 0.00 % -78.57 % 0.00 % 0.00 % 0.00 % 84.77 % 0.00 %
1Y 9 900.00 % 0.00 % -90.00 % 0.00 % -78.57 % 0.00 % 0.00 % 0.00 % 76.04 % 0.00 %
3Y 0.00 % 1 900.00 % -99.23 % -99.78 % -99.25 % 900.00 % -95.74 % 9 900.00 % 198.87 % 0.00 %
5Y -99.63 % -83.33 % -99.87 % -99.00 % -99.51 % 900.00 % -99.39 % 9 900.00 % 94.16 % -90.00 %
10Y -99.89 % -97.78 % -100.00 % -95.71 % -99.93 % 900.00 % -99.39 % 9 900.00 % 86.65 % -88.89 %
From the beginning -100.00 % -99.88 % 13 964.70 % -99.90 % -100.00 % -99.99 % -99.88 % 9 900.00 % 336.91 % -100.00 %

Dividend

Ligand Pharmaceuticals Incorporated